1. Sonnet Bio Spikes 70% In Pre-Market On FDA Covid-19 Plasma Nod
(FDA) has granted an emergency authorization to use blood plasma from recovered Covid-19 patients as a treatment for the disease.
finance.yahoo.com/ne...0-pre-113721579.html
2. Sonnet BioTherapeutics Receives $10.5 Million from Exercise of Series A Warrants
as part of the previously announced warrant exchange agreement, all 3,300,066 Series A Warrants have been exercised at a price of $3.19 per share. Gross proceeds to the Company were $10.5 Million.
After the exercise of these warrants, there are no additional Series A warrants outstanding, which leaves the Company with 2,308,663 Series B Warrants and 11,329,461 Series C Warrants outstanding.
In the event all the Series C Warrants are exercised for cash, the Company could receive up to an additional $36.1 million. With this Series A Warrants exercise, Sonnet's outstanding share count and pro forma fully diluted share count equals 14.7 million and 29.3 million, respectively."
finance.yahoo.com/ne...-10-5-113000091.html
(FDA) has granted an emergency authorization to use blood plasma from recovered Covid-19 patients as a treatment for the disease.
finance.yahoo.com/ne...0-pre-113721579.html
2. Sonnet BioTherapeutics Receives $10.5 Million from Exercise of Series A Warrants
as part of the previously announced warrant exchange agreement, all 3,300,066 Series A Warrants have been exercised at a price of $3.19 per share. Gross proceeds to the Company were $10.5 Million.
After the exercise of these warrants, there are no additional Series A warrants outstanding, which leaves the Company with 2,308,663 Series B Warrants and 11,329,461 Series C Warrants outstanding.
In the event all the Series C Warrants are exercised for cash, the Company could receive up to an additional $36.1 million. With this Series A Warrants exercise, Sonnet's outstanding share count and pro forma fully diluted share count equals 14.7 million and 29.3 million, respectively."
finance.yahoo.com/ne...-10-5-113000091.html